GXLV.L vs. WBIO.L
GXLV.L (SPDR S&P US Health Care Select Sector UCITS ETF) and WBIO.L (WisdomTree BioRevolution UCITS ETF USD Acc) are both Health & Biotech Equities funds - GXLV.L tracks the MSCI World/Health Care NR USD while WBIO.L tracks the NASDAQ Biotechnology TR USD. Both are passively managed. Over the past 3 years, GXLV.L returned 3.78%/yr vs 1.10%/yr for WBIO.L. At a 0.23 correlation, their price movements are largely independent. GXLV.L charges 0.15%/yr vs 0.45%/yr for WBIO.L.
Performance
GXLV.L vs. WBIO.L - Performance Comparison
Loading charts...
Different Trading Currencies
GXLV.L is traded in GBP, while WBIO.L is traded in GBp. To make them comparable, the WBIO.L values have been converted to GBP using the latest available exchange rates.
Returns By Period
In the year-to-date period, GXLV.L achieves a -1.77% return, which is significantly lower than WBIO.L's 10.42% return.
GXLV.L
- 1D
- 2.97%
- 1M
- 5.54%
- YTD
- -1.77%
- 6M
- -1.34%
- 1Y
- 16.55%
- 3Y*
- 3.78%
- 5Y*
- —
- 10Y*
- —
WBIO.L
- 1D
- 4.36%
- 1M
- 4.49%
- YTD
- 10.42%
- 6M
- 10.40%
- 1Y
- 50.88%
- 3Y*
- 1.10%
- 5Y*
- —
- 10Y*
- —
GXLV.L vs. WBIO.L - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
GXLV.L SPDR S&P US Health Care Select Sector UCITS ETF | -1.77% | 6.82% | 3.59% | -3.78% | 7.82% |
WBIO.L WisdomTree BioRevolution UCITS ETF USD Acc | 10.42% | 13.58% | -14.08% | -5.86% | -9.25% |
Correlation
The correlation between GXLV.L and WBIO.L is 0.31, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.31 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.23 |
Correlation (All Time) Calculated using the full available price history since Apr 6, 2022 | 0.23 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
GXLV.L vs. WBIO.L — Risk / Return Rank
GXLV.L
WBIO.L
GXLV.L vs. WBIO.L - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for SPDR S&P US Health Care Select Sector UCITS ETF (GXLV.L) and WisdomTree BioRevolution UCITS ETF USD Acc (WBIO.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| GXLV.L | WBIO.L | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.58 | ||
| Sortino ratioReturn per unit of downside risk | -0.59 | ||
| Omega ratioGain probability vs. loss probability | 1.24 | 1.31 | -0.07 |
| Calmar ratioReturn relative to maximum drawdown | 2.16 | 4.40 | -2.25 |
| Martin ratioReturn relative to average drawdown | 4.76 | 10.38 | -5.62 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| GXLV.L | WBIO.L | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.34 | 1.91 | -0.58 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.31 | -0.19 | +0.51 |
Drawdowns
GXLV.L vs. WBIO.L - Drawdown Comparison
The maximum GXLV.L drawdown since its inception was -19.59%, smaller than the maximum WBIO.L drawdown of -51.13%. Use the drawdown chart below to compare losses from any high point for GXLV.L and WBIO.L.
Loading charts...
Drawdown Indicators
| GXLV.L | WBIO.L | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -19.59% | -51.13% | +31.54% |
Max Drawdown (1Y)Largest decline over 1 year | -11.51% | -11.50% | -0.01% |
Max Drawdown (3Y)Largest decline over 3 years | -19.59% | -39.34% | +19.75% |
Current DrawdownCurrent decline from peak | -5.07% | -18.76% | +13.69% |
Average DrawdownAverage peak-to-trough decline | -6.15% | -26.35% | +20.20% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 9.07% | 4.89% | +4.18% |
Volatility
GXLV.L vs. WBIO.L - Volatility Comparison
The current volatility for SPDR S&P US Health Care Select Sector UCITS ETF (GXLV.L) is 5.53%, while WisdomTree BioRevolution UCITS ETF USD Acc (WBIO.L) has a volatility of 6.84%. This indicates that GXLV.L experiences smaller price fluctuations and is considered to be less risky than WBIO.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| GXLV.L | WBIO.L | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.53% | 6.84% | -1.31% |
Volatility (6M)Calculated over the trailing 6-month period | 12.37% | 17.06% | -4.69% |
Volatility (1Y)Calculated over the trailing 1-year period | 18.62% | 26.57% | -7.95% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 20.60% | 23.70% | -3.10% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 20.60% | 23.70% | -3.10% |
GXLV.L vs. WBIO.L - Expense Ratio Comparison
GXLV.L has a 0.15% expense ratio, which is lower than WBIO.L's 0.45% expense ratio.
Dividends
GXLV.L vs. WBIO.L - Dividend Comparison
Neither GXLV.L nor WBIO.L has paid dividends to shareholders.
Frequently Asked Questions
GXLV.L and WBIO.L have a correlation of 0.31, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, GXLV.L is cheaper at 0.15% per year. The better choice depends on whether you care most about return, fees, risk, or income.
GXLV.L is cheaper with a 0.15% expense ratio, compared with 0.45% for WBIO.L.
GXLV.L tracks MSCI World/Health Care NR USD, while WBIO.L tracks NASDAQ Biotechnology TR USD. They also come from different issuers: State Street and WisdomTree. Their fees differ too: 0.15% for GXLV.L and 0.45% for WBIO.L.
Find the right allocation for GXLV.L and WBIO.L
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer